Skip to content

Current ratio at other companies

CVS Health logo
CVS HealthCVS
0.9×0.0×
Amazon logo
AmazonAMZN
1.2×+0.1×
Doximity logo
DoximityDOCS
6.1×-0.9×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
2.5×+1.1×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
1.7×0.0×
Cencora logo
CencoraCOR
0.9×+0.1×

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-43.1%
Enterprise value$1.24B-34.1%
P/E45.5×-12.3×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s current ratio?
GoodRx Holdings, Inc. (GDRX) reported current ratio of 1.5× in Q1 2026.
How has GoodRx Holdings, Inc.'s current ratio changed year-over-year?
GoodRx Holdings, Inc.'s current ratio decreased by 71.8% year-over-year, from 5.2× to 1.5×.
What is the long-term trend for GoodRx Holdings, Inc.'s current ratio?
Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s current ratio has grown at a -32.2% compound annual growth rate (CAGR), from 18.2× to 2.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.